The following government grants in the FederalGrants.com database contain the term housing in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Head Start and/or Early Head Start Grantee -- Morehouse and West Carroll Parishes, Louisiana |
93.600 |
HHS-2020-ACF-OHS-CH-R06-1609 |
| Advancing Sustained/Extended Release for HIV Prevention (A-SER) (R01 Clinical Trial Not Allowed) |
93.242, 93.855 |
RFA-AI-19-063 |
| Resource-Related Research Projects for Development of Animal Models and Related Materials (R24 Clinical Trials Not-Allowed) |
93.351 |
RFA-OD-19-027 |
| Tailoring Interventions to Improve Preventive Health Service Use (R61/R33 Clinical Trial Required) |
93.866 |
RFA-AG-20-045 |
| Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinical Trial Not Allowed) |
93.307, 93.866 |
PAR-19-372 |
| NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) |
93.855 |
PAR-19-371 |
| Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed) |
93.351 |
PAR-19-369 |
| Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials |
93.233, 93.837, 93.838, 93.839, 93.840 |
RFA-HL-20-028 |
| Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) |
93.847 |
PAR-19-365 |
| Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) |
93.233, 93.837, 93.838, 93.839, 93.840 |
RFA-HL-20-022 |
| Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) |
93.233, 93.837, 93.838, 93.839, 93.840 |
RFA-HL-20-023 |
| State and Regional Primary Care Association (PCA) Cooperative Agreements |
93.129 |
HRSA-20-021 |
| Maximizing Investigators' Research Award (R35 - Clinical Trial Optional) |
93.859 |
PAR-19-367 |
| Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38) (Clinical Trial Not Allowed) |
93.233, 93.394, 93.395, 93.396, 93.397, 93.398, 93.399, 93.837, 93.838, 93.839, 93.840, 93.855, 93.866 |
RFA-HL-20-006 |
| Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) |
93.273, 93.279, 93.399 |
PAR-19-368 |
| Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed) |
93.233, 93.837, 93.838, 93.839, 93.840 |
RFA-HL-20-024 |
| Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed) |
93.233, 93.837, 93.838, 93.839, 93.840 |
RFA-HL-20-027 |
| NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed) |
93.121 |
PAR-19-370 |
| Revision Applications for Mechanisms of Drug Resistance (P50 Clinical Trials Not Allowed) |
93.396 |
RFA-CA-19-053 |
| Revision Applications for Mechanisms of Drug Resistance (P01 Clinical Trials Not Allowed) |
93.396 |
RFA-CA-19-052 |
| Revision Applications for Mechanisms of Drug Resistance (U54 Clinical Trials Not Allowed) |
93.396 |
RFA-CA-19-051 |
| Revision Applications for Mechanisms of Drug Resistance (U01 Clinical Trials Not Allowed) |
93.396 |
RFA-CA-19-050 |
| Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 Clinical Trial Not Allowed) |
93.865 |
RFA-HD-20-020 |
| Peripheral Pathology in the Lewy Body Dementias (R01 Clinical Trial Not Allowed) |
93.853, 93.866 |
RFA-NS-20-014 |
| Revision Applications for Mechanisms of Drug Resistance (R01 Clinical Trials Not Allowed) |
93.396 |
RFA-CA-19-049 |
| Mechanistic Basis of TDP-43-dependent Pathobiology in Common Dementias (R01 Clinical Trial not Allowed) |
93.853, 93.866 |
RFA-NS-20-005 |
| Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium Scientific and Data Coordinating Center (U24 Clinical Trial Optional) |
93.847 |
RFA-DK-19-016 |
| Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium Clinical Research Centers (U01 Clinical Trial Optional) |
93.847, 93.866 |
RFA-DK-19-015 |
| Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) |
93.393, 93.394, 93.395 |
PAR-19-363 |
| The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required) |
93.279 |
RFA-DA-20-024 |
| Trans-Agency Blood-Brain Interface Program (R61/R33 - Clinical Trials Not Allowed) |
93.233, 93.837, 93.838, 93.839, 93.840 |
RFA-HL-20-021 |
| Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R01 Clinical Trial Not Allowed) |
93.855 |
PAR-19-357 |
| Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R21 Clinical Trial Not Allowed) |
93.855 |
PAR-19-364 |
| The NINDS Human Cell and Data Repository (U24 - Clinical Trial Not Allowed) |
93.853 |
RFA-NS-19-038 |
| Clinical Sites for the ECHO IDeA States Pediatric Clinical Trials Network - 2 (UG1 Clinical Trial Required) |
93.279, 93.310, 93.853, 93.855, 93.859, 93.865 |
RFA-OD-19-026 |
| Data Coordinating and Operations Center for the ECHO IDeA States Pediatric Clinical Trials Network - 2 (U24 - Clinical Trial Required -Infrastructure) |
93.279, 93.310, 93.853, 93.855, 93.859, 93.865 |
RFA-OD-19-025 |
| Food as Medicine: Food Insecurity and HIV-related Comorbidities, Coinfections, and Complications within the Mission of the NIDDK (R01 Clinical Trial Optional) |
93.847 |
RFA-DK-19-019 |
| Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01 Clinical Trial Not Allowed) |
93.393, 93.394, 93.396 |
PAR-19-361 |
| Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03 Clinical Trial Optional) |
93.393, 93.395 |
PAR-19-359 |
| Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Peri-operative Pain or Musculoskeletal Trauma (UM1 Clinical Trial Optional) |
93.310 |
RFA-RM-19-013 |
Search Results 5001-5040 of 17636
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 [Next] |
